chr2_+_241193492
|
16.140
|
NM_001195381
NM_001195382
|
GPR35
|
G protein-coupled receptor 35
|
chr10_-_101831579
|
15.596
|
NM_001308
|
CPN1
|
carboxypeptidase N, polypeptide 1
|
chr17_+_24394281
|
14.717
|
|
PIPOX
|
pipecolic acid oxidase
|
chr9_-_126309510
|
14.551
|
NM_004959
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
chr12_+_51783540
|
14.542
|
NM_003578
|
SOAT2
|
sterol O-acyltransferase 2
|
chr12_+_51783554
|
14.195
|
|
SOAT2
|
sterol O-acyltransferase 2
|
chr10_+_102722275
|
13.548
|
NM_017893
|
SEMA4G
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G
|
chr3_-_52454082
|
13.263
|
NM_020163
|
SEMA3G
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3G
|
chr1_+_15941503
|
12.890
|
NM_001013641
|
TMEM82
|
transmembrane protein 82
|
chr6_+_131190237
|
12.685
|
NM_001195597
|
LOC285733
|
hypothetical LOC285733
|
chr9_-_14858974
|
12.645
|
|
FREM1
|
FRAS1 related extracellular matrix 1
|
chr1_-_167822248
|
11.880
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
chr13_+_112825113
|
11.690
|
NM_000504
|
F10
|
coagulation factor X
|
chr17_+_69950782
|
11.294
|
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C
|
chr6_+_31731667
|
11.255
|
|
APOM
|
apolipoprotein M
|
chr2_-_74606819
|
11.222
|
NM_133637
|
DQX1
|
DEAQ box RNA-dependent ATPase 1
|
chr14_-_23847000
|
11.136
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
chr6_+_31731647
|
11.095
|
NM_019101
|
APOM
|
apolipoprotein M
|
chr17_-_31353196
|
10.782
|
NM_032965
|
CCL15
|
chemokine (C-C motif) ligand 15
|
chr8_+_21972631
|
10.695
|
NM_001114138
NM_001978
|
EPB49
|
erythrocyte membrane protein band 4.9 (dematin)
|
chr16_-_86527608
|
10.676
|
NM_001739
|
CA5A
|
carbonic anhydrase VA, mitochondrial
|
chr8_+_21972804
|
10.512
|
|
EPB49
|
erythrocyte membrane protein band 4.9 (dematin)
|
chr14_-_23847024
|
10.428
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
chr9_-_129752687
|
10.418
|
NM_203305
|
FAM102A
|
family with sequence similarity 102, member A
|
chr14_-_23846993
|
10.414
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
chr14_-_23846904
|
10.274
|
|
CIDEB
|
cell death-inducing DFFA-like effector b
|
chr2_-_238164042
|
10.065
|
|
RAB17
|
RAB17, member RAS oncogene family
|
chr16_+_21152516
|
10.006
|
NM_145865
|
ANKS4B
|
ankyrin repeat and sterile alpha motif domain containing 4B
|
chr1_-_110108048
|
9.669
|
NM_024526
NM_133181
NM_139053
|
EPS8L3
|
EPS8-like 3
|
chr14_-_93924873
|
9.598
|
NM_000295
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
chr20_-_3097070
|
9.569
|
NM_014731
|
ProSAPiP1
|
ProSAPiP1 protein
|
chr22_+_43451600
|
9.429
|
|
PRR5
|
proline rich 5 (renal)
|
chr19_+_4104593
|
9.426
|
NM_032607
|
CREB3L3
|
cAMP responsive element binding protein 3-like 3
|
chr1_-_172153024
|
9.372
|
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
chr1_-_172153087
|
9.333
|
NM_000488
|
SERPINC1
|
serpin peptidase inhibitor, clade C (antithrombin), member 1
|
chr6_+_30238961
|
9.210
|
NM_033229
|
TRIM15
|
tripartite motif containing 15
|
chr16_-_51138306
|
9.181
|
NM_001080430
|
TOX3
|
TOX high mobility group box family member 3
|
chr1_-_167822334
|
9.113
|
NM_000130
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
chr19_-_63715135
|
8.985
|
NM_012254
|
SLC27A5
|
solute carrier family 27 (fatty acid transporter), member 5
|
chr17_-_31352720
|
8.973
|
|
CCL14-CCL15
|
CCL14-CCL15 read-through transcript
|
chr17_-_31352643
|
8.882
|
|
CCL14-CCL15
CCL15
|
CCL14-CCL15 read-through transcript
chemokine (C-C motif) ligand 15
|
chr6_+_32090516
|
8.785
|
NM_007293
NM_001002029
|
C4A
C4B
|
complement component 4A (Rodgers blood group)
complement component 4B (Chido blood group)
|
chr2_+_218992053
|
8.744
|
NM_007127
|
VIL1
|
villin 1
|
chr1_-_153537810
|
8.492
|
NM_000298
|
PKLR
|
pyruvate kinase, liver and RBC
|
chr17_+_35147697
|
8.433
|
NM_005310
|
GRB7
|
growth factor receptor-bound protein 7
|
chr11_-_116213511
|
8.156
|
NM_000039
|
APOA1
|
apolipoprotein A-I
|
chr20_+_55569542
|
8.121
|
NM_002591
|
PCK1
|
phosphoenolpyruvate carboxykinase 1 (soluble)
|
chr20_+_35406497
|
8.118
|
NM_005417
|
SRC
|
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian)
|
chr19_+_46640902
|
8.085
|
NM_001130514
|
C19orf69
|
chromosome 19 open reading frame 69
|
chr20_+_34937928
|
8.082
|
NM_080628
|
C20orf118
|
chromosome 20 open reading frame 118
|
chr5_-_42847716
|
8.068
|
NM_001085486
NM_001093726
NM_005410
|
SEPP1
|
selenoprotein P, plasma, 1
|
chr7_+_101704145
|
8.016
|
|
CUX1
|
cut-like homeobox 1
|
chr2_-_238164452
|
7.963
|
NM_022449
|
RAB17
|
RAB17, member RAS oncogene family
|
chr16_+_464844
|
7.815
|
NM_001142272
|
RAB11FIP3
|
RAB11 family interacting protein 3 (class II)
|
chr1_-_176205970
|
7.725
|
|
SEC16B
|
SEC16 homolog B (S. cerevisiae)
|
chr6_+_32021793
|
7.723
|
|
CFB
|
complement factor B
|
chr1_-_176205672
|
7.553
|
NM_033127
|
SEC16B
|
SEC16 homolog B (S. cerevisiae)
|
chr17_+_24394043
|
7.495
|
NM_016518
|
PIPOX
|
pipecolic acid oxidase
|
chr11_+_60858611
|
7.422
|
|
DAK
|
dihydroxyacetone kinase 2 homolog (S. cerevisiae)
|
chr12_+_119900931
|
7.365
|
NM_000545
|
HNF1A
|
HNF1 homeobox A
|
chr1_-_159459814
|
7.328
|
|
APOA2
|
apolipoprotein A-II
|
chr19_-_55708936
|
7.312
|
NM_001114598
|
ASPDH
|
aspartate dehydrogenase domain containing
|
chr20_-_52120421
|
7.271
|
|
BCAS1
|
breast carcinoma amplified sequence 1
|
chr2_+_242398954
|
7.238
|
|
NEU4
|
sialidase 4
|
chr17_+_38259620
|
7.188
|
|
AOC3
|
amine oxidase, copper containing 3 (vascular adhesion protein 1)
|
chr17_-_33179118
|
7.185
|
NM_000458
NM_001165923
|
HNF1B
|
HNF1 homeobox B
|
chr1_+_1351370
|
7.162
|
NM_001146685
|
TMEM88B
|
transmembrane protein 88B
|
chr2_+_11597530
|
7.117
|
NM_148903
|
GREB1
|
growth regulation by estrogen in breast cancer 1
|
chr19_+_40321584
|
7.071
|
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
chr2_+_27573206
|
7.056
|
NM_001486
|
GCKR
|
glucokinase (hexokinase 4) regulator
|
chr20_-_52120710
|
7.035
|
NM_003657
|
BCAS1
|
breast carcinoma amplified sequence 1
|
chr17_-_33178987
|
7.013
|
|
HNF1B
|
HNF1 homeobox B
|
chr3_-_195553297
|
6.989
|
NM_001080513
|
CPN2
|
carboxypeptidase N, polypeptide 2
|
chr6_-_31953425
|
6.929
|
NM_001178045
|
SLC44A4
|
solute carrier family 44, member 4
|
chr10_-_76529253
|
6.908
|
NM_016364
|
DUSP13
|
dual specificity phosphatase 13
|
chr15_+_83228895
|
6.865
|
NM_004213
NM_201651
|
SLC28A1
|
solute carrier family 28 (sodium-coupled nucleoside transporter), member 1
|
chr17_-_7023378
|
6.833
|
NM_001197216
NM_001671
|
ASGR1
|
asialoglycoprotein receptor 1
|
chr1_-_24307514
|
6.788
|
|
MYOM3
|
myomesin family, member 3
|
chr16_-_45339605
|
6.764
|
NM_182493
|
MYLK3
|
myosin light chain kinase 3
|
chr10_-_74384485
|
6.759
|
NM_032562
|
PLA2G12B
|
phospholipase A2, group XIIB
|
chr3_-_58497913
|
6.748
|
NM_003500
|
ACOX2
|
acyl-CoA oxidase 2, branched chain
|
chr1_+_226404037
|
6.622
|
NM_020435
|
GJC2
|
gap junction protein, gamma 2, 47kDa
|
chr5_+_133870175
|
6.575
|
|
|
|
chr7_-_100630912
|
6.568
|
NM_178176
|
MOGAT3
|
monoacylglycerol O-acyltransferase 3
|
chr19_-_18196302
|
6.551
|
NM_001098819
|
PDE4C
|
phosphodiesterase 4C, cAMP-specific
|
chr19_+_40321567
|
6.506
|
NM_021902
|
FXYD1
|
FXYD domain containing ion transport regulator 1
|
chr1_-_228916559
|
6.505
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
chr15_+_41672543
|
6.476
|
NM_020990
|
CKMT1B
CKMT1A
|
creatine kinase, mitochondrial 1B
creatine kinase, mitochondrial 1A
|
chr12_+_119900677
|
6.471
|
|
HNF1A
|
HNF1 homeobox A
|
chr10_-_74384569
|
6.453
|
|
PLA2G12B
|
phospholipase A2, group XIIB
|
chr17_+_4621924
|
6.401
|
NM_003963
|
TM4SF5
|
transmembrane 4 L six family member 5
|
chr6_+_32003380
|
6.355
|
|
C2
|
complement component 2
|
chr19_-_15906669
|
6.347
|
NM_001128932
NM_021187
|
CYP4F11
|
cytochrome P450, family 4, subfamily F, polypeptide 11
|
chr8_-_82769761
|
6.280
|
NM_001010893
|
SLC10A5
|
solute carrier family 10 (sodium/bile acid cotransporter family), member 5
|
chr13_+_112808102
|
6.265
|
NM_000131
NM_019616
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
chr10_+_114123828
|
6.113
|
NM_203379
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5
|
chr6_+_32021742
|
6.056
|
|
CFB
|
complement factor B
|
chr8_-_110773195
|
6.041
|
NM_001099743
NM_001099744
|
SYBU
|
syntabulin (syntaxin-interacting)
|
chr6_+_32057779
|
6.039
|
NM_007293
NM_001002029
|
C4A
C4B
|
complement component 4A (Rodgers blood group)
complement component 4B (Chido blood group)
|
chr20_-_32363268
|
6.021
|
NM_001161766
|
AHCY
|
adenosylhomocysteinase
|
chr2_+_219354692
|
5.961
|
NM_000784
|
CYP27A1
|
cytochrome P450, family 27, subfamily A, polypeptide 1
|
chr4_-_9632192
|
5.948
|
NM_020041
|
SLC2A9
|
solute carrier family 2 (facilitated glucose transporter), member 9
|
chr17_+_35147738
|
5.890
|
|
GRB7
|
growth factor receptor-bound protein 7
|
chr11_+_46697345
|
5.884
|
|
F2
|
coagulation factor II (thrombin)
|
chr19_-_19142053
|
5.809
|
|
MEF2B
|
myocyte enhancer factor 2B
|
chr1_-_153537362
|
5.794
|
NM_181871
|
PKLR
|
pyruvate kinase, liver and RBC
|
chr17_-_71352090
|
5.787
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
chr17_-_68769613
|
5.748
|
NM_001129885
|
CPSF4L
|
cleavage and polyadenylation specific factor 4-like
|
chr11_+_46697312
|
5.704
|
NM_000506
|
F2
|
coagulation factor II (thrombin)
|
chr17_-_71352017
|
5.703
|
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
chr11_+_46697335
|
5.699
|
|
F2
|
coagulation factor II (thrombin)
|
chr2_-_88208650
|
5.658
|
NM_001443
|
FABP1
|
fatty acid binding protein 1, liver
|
chr1_-_159459999
|
5.584
|
NM_001643
|
APOA2
|
apolipoprotein A-II
|
chr6_+_32021831
|
5.559
|
|
CFB
|
complement factor B
|
chr2_+_113648036
|
5.501
|
|
PSD4
|
pleckstrin and Sec7 domain containing 4
|
chr22_+_43451351
|
5.473
|
NM_001017530
NM_001198721
NM_015366
|
PRR5
|
proline rich 5 (renal)
|
chr17_-_71352182
|
5.434
|
NM_199242
|
UNC13D
|
unc-13 homolog D (C. elegans)
|
chr1_-_1346465
|
5.430
|
NM_001145210
|
LOC441869
|
hypothetical protein LOC441869
|
chr7_-_50600536
|
5.430
|
NM_001082971
|
DDC
|
dopa decarboxylase (aromatic L-amino acid decarboxylase)
|
chr16_+_29597965
|
5.407
|
|
QPRT
|
quinolinate phosphoribosyltransferase
|
chr19_-_38052481
|
5.386
|
NM_001126335
NM_014270
|
SLC7A9
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 9
|
chr1_-_149611768
|
5.370
|
NM_003944
|
SELENBP1
|
selenium binding protein 1
|
chr2_-_233586145
|
5.352
|
|
NGEF
|
neuronal guanine nucleotide exchange factor
|
chrX_+_152565849
|
5.346
|
|
DUSP9
|
dual specificity phosphatase 9
|
chr10_+_114123765
|
5.317
|
|
ACSL5
|
acyl-CoA synthetase long-chain family member 5
|
chr12_-_55637648
|
5.310
|
NM_003708
|
RDH16
|
retinol dehydrogenase 16 (all-trans)
|
chr20_+_31059038
|
5.271
|
NM_025227
|
BPIL1
|
bactericidal/permeability-increasing protein-like 1
|
chr12_+_56114724
|
5.259
|
NM_005538
|
INHBC
|
inhibin, beta C
|
chr6_+_32003180
|
5.221
|
NM_000063
NM_001145903
|
C2
|
complement component 2
|
chr11_-_116168316
|
5.220
|
NM_001166598
NM_052968
|
APOA5
|
apolipoprotein A-V
|
chr14_-_93924663
|
5.212
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
chr7_+_142692165
|
5.181
|
NM_153345
|
TMEM139
|
transmembrane protein 139
|
chr2_-_233586164
|
5.139
|
NM_019850
|
NGEF
|
neuronal guanine nucleotide exchange factor
|
chr6_-_29635456
|
5.136
|
|
UBD
|
ubiquitin D
|
chr11_-_64520964
|
5.104
|
NM_138456
|
BATF2
|
basic leucine zipper transcription factor, ATF-like 2
|
chr13_+_49658016
|
5.049
|
|
|
|
chr17_-_33982580
|
5.014
|
|
SRCIN1
|
SRC kinase signaling inhibitor 1
|
chr17_+_38306339
|
5.007
|
NM_000151
|
G6PC
|
glucose-6-phosphatase, catalytic subunit
|
chr16_+_55963883
|
4.981
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
chr12_-_53065758
|
4.955
|
|
ZNF385A
|
zinc finger protein 385A
|
chr2_+_218929822
|
4.954
|
NM_198559
|
C2orf62
|
chromosome 2 open reading frame 62
|
chr12_-_1791146
|
4.945
|
|
CACNA2D4
|
calcium channel, voltage-dependent, alpha 2/delta subunit 4
|
chr16_+_2954217
|
4.944
|
NM_024507
NM_172229
|
KREMEN2
|
kringle containing transmembrane protein 2
|
chr8_-_142307854
|
4.923
|
NM_001080431
|
SLC45A4
|
solute carrier family 45, member 4
|
chr11_+_73036241
|
4.904
|
NM_001130034
NM_001130035
|
PLEKHB1
|
pleckstrin homology domain containing, family B (evectins) member 1
|
chr19_-_63556632
|
4.885
|
NM_130786
|
A1BG
|
alpha-1-B glycoprotein
|
chr6_-_31853027
|
4.855
|
NM_025258
|
C6orf27
|
chromosome 6 open reading frame 27
|
chr3_-_42892195
|
4.842
|
|
CYP8B1
|
cytochrome P450, family 8, subfamily B, polypeptide 1
|
chr12_+_107797985
|
4.798
|
NM_001917
|
DAO
|
D-amino-acid oxidase
|
chr3_-_121883647
|
4.797
|
|
HGD
|
homogentisate 1,2-dioxygenase
|
chr1_-_11029882
|
4.789
|
|
MASP2
|
mannan-binding lectin serine peptidase 2
|
chr20_+_42417502
|
4.769
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
chr2_+_10009242
|
4.731
|
NM_198182
|
GRHL1
|
grainyhead-like 1 (Drosophila)
|
chr1_-_228916958
|
4.713
|
NM_000029
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
chr5_-_16791346
|
4.692
|
|
MYO10
|
myosin X
|
chr10_+_60607232
|
4.668
|
NM_001143774
|
PHYHIPL
|
phytanoyl-CoA 2-hydroxylase interacting protein-like
|
chr17_-_6958773
|
4.659
|
NM_001181
NM_080912
NM_080913
|
ASGR2
|
asialoglycoprotein receptor 2
|
chr8_+_22909305
|
4.657
|
NM_001160037
|
RHOBTB2
|
Rho-related BTB domain containing 2
|
chr19_-_4491078
|
4.641
|
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1
|
chr4_-_1156959
|
4.628
|
NM_001128325
|
SPON2
|
spondin 2, extracellular matrix protein
|
chr4_+_100714995
|
4.596
|
|
MTTP
|
microsomal triglyceride transfer protein
|
chr19_+_6415259
|
4.591
|
NM_139161
NM_174881
|
CRB3
|
crumbs homolog 3 (Drosophila)
|
chr17_+_73638430
|
4.566
|
NM_152468
|
TMC8
|
transmembrane channel-like 8
|
chr12_-_7935010
|
4.563
|
|
SLC2A14
|
solute carrier family 2 (facilitated glucose transporter), member 14
|
chr22_-_31784328
|
4.548
|
NM_001135774
|
SYN3
|
synapsin III
|
chr1_+_38033666
|
4.536
|
NM_152496
|
MANEAL
|
mannosidase, endo-alpha-like
|
chr19_-_15451203
|
4.533
|
NM_052890
|
PGLYRP2
|
peptidoglycan recognition protein 2
|
chr16_-_16224791
|
4.526
|
NM_001079528
NM_001171
|
ABCC6
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 6
|
chr12_-_120781002
|
4.502
|
NM_002150
|
HPD
|
4-hydroxyphenylpyruvate dioxygenase
|
chr10_+_103976132
|
4.417
|
NM_152310
|
ELOVL3
|
elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 3
|
chr17_-_23721351
|
4.385
|
|
VTN
|
vitronectin
|
chr17_-_71535076
|
4.370
|
NM_001988
|
EVPL
|
envoplakin
|
chr17_-_6958695
|
4.352
|
|
ASGR2
|
asialoglycoprotein receptor 2
|
chr19_-_19142090
|
4.351
|
NM_001145785
|
MEF2B
|
myocyte enhancer factor 2B
|
chr3_-_197422653
|
4.350
|
NM_001039617
|
ZDHHC19
|
zinc finger, DHHC-type containing 19
|
chr10_+_51246290
|
4.331
|
NM_001145262
|
NCOA4
|
nuclear receptor coactivator 4
|
chr10_+_101532544
|
4.326
|
|
ABCC2
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 2
|
chr6_+_33280396
|
4.278
|
NM_014234
|
HSD17B8
|
hydroxysteroid (17-beta) dehydrogenase 8
|
chr8_+_144192011
|
4.277
|
NM_173687
|
C8orf31
|
chromosome 8 open reading frame 31
|
chr17_+_72958207
|
4.267
|
NM_001113496
|
SEPT9
|
septin 9
|
chr2_+_242398832
|
4.258
|
NM_001167600
NM_001167601
|
NEU4
|
sialidase 4
|
chr17_+_69939130
|
4.218
|
NM_022036
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C
|
chr17_+_1593040
|
4.214
|
NM_001165920
|
SERPINF2
|
serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2
|
chr17_+_45405128
|
4.210
|
NM_001934
|
DLX4
|
distal-less homeobox 4
|
chr3_-_10522340
|
4.195
|
|
ATP2B2
|
ATPase, Ca++ transporting, plasma membrane 2
|
chr16_+_56211410
|
4.178
|
NM_001145770
NM_005682
|
GPR56
|
G protein-coupled receptor 56
|
chr16_+_68542126
|
4.177
|
NM_001136214
|
CLEC18A
|
C-type lectin domain family 18, member A
|
chr1_+_144439069
|
4.176
|
NM_002614
|
PDZK1
|
PDZ domain containing 1
|
chr19_-_4491024
|
4.175
|
NM_052972
|
LRG1
|
leucine-rich alpha-2-glycoprotein 1
|
chr16_-_54424517
|
4.137
|
NM_001025194
NM_001025195
NM_001266
|
CES1
|
carboxylesterase 1
|
chr1_-_6343306
|
4.124
|
NM_181865
|
ACOT7
|
acyl-CoA thioesterase 7
|
chr1_+_26220852
|
4.116
|
NM_004455
|
EXTL1
|
exostoses (multiple)-like 1
|
chr20_+_42417752
|
4.098
|
NM_001030003
NM_001030004
NM_175914
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
chr1_+_203740391
|
4.094
|
|
CDK18
|
cyclin-dependent kinase 18
|
chr16_-_30032330
|
4.057
|
NM_024307
|
GDPD3
|
glycerophosphodiester phosphodiesterase domain containing 3
|
chr21_+_41616590
|
4.049
|
|
FAM3B
|
family with sequence similarity 3, member B
|
chr3_-_49434874
|
4.042
|
|
AMT
|
aminomethyltransferase
|
chr17_+_4795128
|
4.030
|
NM_001193503
NM_001976
NM_053013
|
ENO3
|
enolase 3 (beta, muscle)
|
chr3_-_198784590
|
3.976
|
NM_203315
|
BDH1
|
3-hydroxybutyrate dehydrogenase, type 1
|
chr17_+_71582486
|
3.970
|
NM_003857
|
GALR2
|
galanin receptor 2
|